Current guidelines from both the U.S. Preventive Services Task Force (USPSTF) and the American Cancer Society recommend stopping cervical cancer screening at age 65, but only if you have a history of consistently normal results. The logic is straightforward: if decades of screening have never found a problem, the chances of developing cervical cancer after 65 are very low. But “very low” isn’t zero, and the recommendation has drawn criticism because roughly 20% of new cervical cancer diagnoses still occur in women 65 and older.
What “Adequately Screened” Actually Means
The age cutoff comes with a major condition that often gets lost in conversation: you qualify to stop screening only if you’ve been “adequately screened” with normal results. That has a specific definition. You need either three consecutive negative Pap tests or two consecutive negative HPV tests (or co-tests combining both) within the 10 years before you stop, with the most recent test done within the past 5 years.
If you haven’t met that threshold, perhaps because you skipped screenings during your 50s or early 60s, the recommendation to stop at 65 does not apply to you. You’d need to continue testing until you’ve accumulated that track record of normal results.
The Medical Reasoning Behind the Cutoff
Cervical cancer is caused by persistent infection with high-risk strains of HPV. The progression from a new HPV infection to detectable precancerous changes is slow, and most HPV infections clear on their own within about a year. The median duration of an HPV infection is roughly 11 to 12 months, even for the highest-risk strains like HPV-16 and HPV-18. When infections don’t clear, it typically takes many more years before precancerous cells develop into invasive cancer.
This long timeline is the key. If a woman has been screened regularly for decades and has never shown signs of HPV-related cell changes, the probability that she’s harboring an undetected, slow-growing lesion is extremely small. The screening has effectively ruled it out over and over again.
Why Screening After 65 Can Cause Harm
Stopping screening isn’t just about saving time or money. After menopause, changes in vaginal and cervical tissue make Pap smears less reliable. Thinning tissue (atrophy) can look abnormal under a microscope, leading to false positive results. One study of postmenopausal women found that 96% of abnormal Pap smear results were the mildest category of abnormality, and 70% of those were HPV-negative, meaning the “abnormal” finding wasn’t caused by a real infection.
Each false positive triggers follow-up: repeat testing, colposcopy (a closer examination of the cervix), and sometimes biopsies. These procedures carry physical discomfort, anxiety, and cost, all without detecting any actual disease. The USPSTF gave the recommendation to stop screening at 65 a “D” grade, which means they found moderate to high certainty that continuing routine screening in adequately screened women produces harms that outweigh the benefits.
The Numbers That Complicate Things
The case for stopping isn’t as clean as it might seem. National cancer data shows that 12.6% of new cervical cancer cases occur in women aged 65 to 74, another 6.2% in women 75 to 84, and 2.3% in women over 84. The mortality picture is even more striking: 20.3% of cervical cancer deaths occur in the 65-to-74 age group, and 12.1% in women 75 to 84. Combined, women over 65 account for nearly 39% of all cervical cancer deaths.
These numbers have led some researchers to argue the current guidelines need revisiting. A significant portion of the women diagnosed after 65 were never adequately screened in the first place, or they had gaps in their screening history. But the high death rate also reflects the fact that cancers found after screening stops tend to be caught at later, less treatable stages.
When Screening Should Continue Past 65
Several situations call for continued screening regardless of age:
- History of precancerous changes. If you’ve ever been treated for high-grade precancerous lesions (CIN 2, CIN 3, or adenocarcinoma in situ), guidelines recommend continuing routine screening for at least 20 years after treatment, even if that takes you well past 65.
- Inadequate screening history. If you haven’t had the required number of consecutive normal results in the past 10 years, you should keep screening until you do.
- Weakened immune system. Women living with HIV or taking immunosuppressive medications for organ transplants, lupus, or other conditions face a higher risk of HPV persistence and cervical disease. Updated guidelines recommend these women continue screening through their lifetime, with decisions about stopping based on individual circumstances and quality of life.
After a Hysterectomy
If you’ve had a total hysterectomy, meaning the uterus and cervix were both removed, for a reason unrelated to cancer or precancerous changes, you no longer have cervical tissue to screen. In that case, Pap smears are unnecessary at any age. However, if the hysterectomy was performed because of cervical cancer or high-grade precancerous cells, or if only the uterus was removed and the cervix remains, screening should continue on the same schedule as someone who hasn’t had surgery.
What This Means in Practice
The recommendation to stop Pap smears at 65 is not a blanket rule. It’s conditional on a clean screening history. If your records show years of normal results with no gaps, the evidence supports stopping. The risk of a new cervical cancer developing at that point is genuinely very small, and the risk of a false alarm from an unreliable test is real.
If your screening history is incomplete, if you’ve had abnormal results in the past, or if you have a condition that affects your immune system, the calculus changes. In those cases, the benefits of continued screening outweigh the downsides. The most important step is knowing your own history: when your last test was, what the results were, and whether you meet the specific criteria for safe exit from screening.